The loop system between neuropeptide Y and leptin in normal and obese rodents

Hormone and Metabolic Research

Volumn 28, Issue 12, 1996, Pages 642-648

  Rohner Jeanrenaud, F ^a   Cusin, I ^a   Sainsbury, A ^a   Zakrzewska, K E ^a   Jeanrenaud, B ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

CNS; hypercorticosteronemia; hyperinsulinemia; hypothalamo pituitary adrenal (HPA) axis; leptin; neuropeptide Y; neuropeptide Y in adrenalectomized rats; ob ob mice; obese fa fa rats; obesity

Indexed keywords

INSULIN; LEPTIN; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL TISSUE; COLD ACCLIMATIZATION; CONTROLLED STUDY; ENERGY METABOLISM; FEEDBACK SYSTEM; FOOD INTAKE; HYPOTHALAMUS; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0030481072     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979870     Document Type: Review

References (61)

1. Bray GA: Obesity, a disorder of nutrient partitioning: The Mona Lisa hypothesis. J Nutr 121: 1146-1162 (1991).
2. Rohner-Jeanrenaud F: A neuroendocrine reappraisal of the dual-centre hypothesis: its implications for obesity and insulin resistance. Int J Obes 19: 517-534 (1995).
3. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte Jr D: Insulin in the brain: a hormonal regulator of energy balance. Endorine Rev 13: 387-414 (1992).
4. Tatemoto K, Carlquist M, Mutt V: Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659-660 (1982).
5. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432 (1994).
6. Clark JT, Kalra PS, Crowley WR, Kalra SP: Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115: 427-429 (1984).
7. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF: Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides 7: 1189-1192 (1986).
8. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549 (1995).
9. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Vurley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546 (1995).
10. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543 (1995)
11. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B: Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133: 1753-1758 (1993).
12. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B: Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 43: 764-769 (1994).
13. Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B: Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37: 1202-1208 (1994)
14. Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue. Diabetologia 39: 353-356 (1996).
15. Sainsbury A, Rohner-Jeanrenaud F, Cusin I, Jeanrenaud B: Longitudinal study of hormonal changes observed during chronic central neuropeptide Y infusion in normal rats. (Submitted for publication 1996).
16. Ong JM, Kirchgessner TG, Schotz MC, Kern PA: Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes. J Biol Chem 263: 12933-12938 (1988).
17. Terrettaz J, Cusin I, Etienne J, Jeanrenaud B: In vivo regulation of adipose tissue lipoprotein lipase in normal rats made hyper-insulinemic and in hyperinsulinemic genetically-obese (fa/fa) rats. Int J Obes 18: 9-15 (1994).
18. Vydelingum N, Drake RL, Etienne J, Kissebah AH: Insulin regulation of fat cell ribosome, protein synthesis, and lipoprotein lipase. Am J Physiol 245: E121-E131 (1983).
19. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes 44: 1467-1470 (1995).
20. Leroy P, Dessolin S, Villageois P, Chun Moon B, Friedman JM, Ailhaud C, Dani C: Expression of ob gene in adipose cells. J Biol Chem 271: 2365-2368 (1996).
21. Mizuno TM, Bergen H, Funabashi T, Kleopoulos SP, Zhong Y-G, Bauman WA, Mobbs CV: Obese gene expression: Reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity. Proc Natl Acad Sci USA 93: 3434-3438 (1996).
22. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake or insulin administration. Nature 377: 527-529 (1995).
23. Sivitz WI, Bailey HL, Donohoue P: Rat adipose ob mRNA levels in states of altered circulating glucose and insulin. Biochem Biophys Res Commun 220: 520-525 (1996).
24. Zheng D, Jones YP, Usala SJ, Dohm GL: Differential expression of ob mRNA in rat adipose tissues in response to insulin. Biochem Biophys Res Commun 218: 434-437 (1996).
25. Hardie LJ, Rayner DV, Holmes S, Trayhurn P: Circulating leptin levels are modulated by fasting, cold exposure and insulin administration to lean but not Zucker (fa/fa) rats as measured by ELISA. Biochem Biophys Res Commun 223: 660-665 (1996).
26. Trayhurn P, Duncan JS, Rayner DV: Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem J 311: 729-733 (1995).
27. Cusin I, Rohner-Jeanrenaud F, Stricker-Krongrad A, Jeanrenaud B: Weight-reducing effect of intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats: reduced sensitivity compared to lean animals. Diabetes 45: 1446-1451 (1996).
28. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte Jr D, Woods SC, Seeley RJ, Weigle DS: Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45: 531-535 (1996).
29. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck Jr PR, Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530-532 (1995).
30. De Vos P, Saladin R, Auwerx J, Staels B: Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 270: 15958-15961 (1995).
31. Murakami T, Iida M, Shima K: Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem Biophys Res Commun 214: 1260-1267 (1995).
32. Rentsch J, Chiesi M: Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Letters 379: 55-59 (1996).
33. Slicker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuier F, Manetta J, Bue-Valleskey J, Stephens TW: Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 271: 5301-5304 (1996).
34. Castonguay TW, Dallman MF, Stern JS: Some metabolic and behavioral effects of adrenalectomy on obese Zucker rats. Am J Physiol 251: R923-R933 (1986).
35. Feldkircher KM, Mistry AM, Romsos DR: Adrenalectomy reverses pre-existing obesity in adult genetically obese (ob/ob) mice. Int J Obes 20: 232-235 (1996).
36. Freedman MR, Horwitz BA, Stern JS: Effect of adrenalectomy and glucocorticoid replacement on development of obesity. Am J Physiol 250: R595-R607 (1986).
37. Okada S, Onai T, Kilroy G, York DA, Bray GA: Adrenalectomy of the obese Zucker rat: effects on the feeding response to enterostatin and specific mRNA levels. Am J Physiol 265: R21-R27 (1993).
38. Yukimura Y, Bray GA: Effects of adrenalectomy on body weight and the size and number of fat cells in the Zucker (fatty) rat. Endocrine Research Comm 5: 189-198 (1978).
39. Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B: Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats. Diabetes (in press, 1996).
40. Masuzaki H, Hosoda K, Ogawa Y, Shigemoto M, Satoh N, Mori K, Tamura N, Nishi S, Yoshimasa Y, Yamori Y, Nakao K: Augmented expression of obese (ob) gene during the process of obesity in genetically obese-hyperglycemic Wistar fatty (fa/fa) rats. FEBS Letters 378: 267-271 (1996).
41. Frederich RC, Lollmann B, Hamann A, Napolitano-Rosen A, Kahn BB, Lowell BB, Flier JS: Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 96: 1658-1663 (1995).
42. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1: 1155-1161 (1995).
43. Malmström R, Taskinen M-R, Karonen S-L, Yki-Järvinen H: Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 39: 993-996 (1996).
44. McGregor GP, Desaga JF, Ehlenz K, Fischer A, Heese F, Hegele A, Lämmer C, Peiser C, Lang RE: Radioimmunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 137: 1501-1504 (1995).
45. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, Caro JF: Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 97: 1344-1347 (1996).
46. Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF: The hypothalamic leptin receptor in humans. Identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 45: 992-994 (1996).
47. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP: Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495 (1996).
48. Devos R, Richards JG, Campfield LA, Tartaglia LA, Guisez Y, Van der Heyden J, Travernier J, Plaetnick G, Burn P: OB protein binds specifically to the choroid plexus of mice and rats. Proc Natl Acad Sci USA 93: 5668-5673 (1996).
49. Lee G-H, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635 (1996).
50. Lynn RB, Cao G-Y, Considine RV, Hyde TM, Caro JF: Autoradiographic localization of leptin binding in the choroid plexus of ob/ob and db/db mice. Biochem Biophys Res Commun 219: 884-889 (1996)
51. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P: Localization of leptin receptor mRNA and the long form slice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Letters 387: 113-116 (1996).
52. Dryden S, Frankish H, Wang Q, Williams G: Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur J Clin Invest 24: 293-308 (1994).
53. Beck B, Burlet A, Nicolas JP, Burlet C: Hypothalamic neuropeptide Y in obese Zucker rats: Implications in feeding and sexual behaviors. Physiol Behav 47: 449-453 (1990).
54. Chua SC, White DW, Wu-Peng XS, Liu SM, Okada N, Kershaw EE, Chung WK, Power-Kehoe L, Chua M, Tartaglia LA, Leibel RL: Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr). Diabetes 45: 1141-1143 (1996).
55. Iida M, Murakami T, Ishida K, Mizuno A, Kuwajima M, Shima K: Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa/fa) rat. Biochem Biophys Res Commun 222: 19-26 (1996).
56. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CT, Hess JF: Leptin receptor missense mutation in the fatty Zucker rat. Nature Genetics 13: 18-19 (1996).
57. Giese K, Fantl WJ, Vitt C, Stephans JC, Cousens L, Wachowicz M, Williams LT: Reduction of food intake and weight gain by the ob protein requires a specific secondary structure and is reversible. Mol Med 2: 50-58 (1996).
58. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephans TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295 (1996).
59. Hassink SG, Sheslow DV, De Lancey E, Opentanova I, Considine RV, Caro JF: Serum leptin in children with obesity: relationship to gender and development. Pediatrics 98: 201-203 (1996).
60. Hosoda K, Yasuno A, Masuzaki H, Ogawa Y, Miyawaki T, Hiraoka J, Hanaoka I, Nomura T, Fujisawa Y, Yoshimasa Y, Nishi S, Yamori Y, Nakao K: Development of radioimmunoassay for human leptin. Biochem Biophys Res Commun 221: 234-239 (1996).
61. Klein S, Coppack SW, Mohamed-Ali V, Landt M: Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45: 984-987 (1996).